You are here

Multiple sclerosis molecule 'key in condition'

Multiple sclerosis molecule 'key in condition'
26th April 2011

New research into multiple sclerosis has presented the possibility of a new treatment for the condition.

A study published in Nature Immunology has identified a molecule known as GM-CSF that plays a key role in autoimmune diseases such as multiple sclerosis.

The scientists, from Thomas Jefferson University, believe that finding a way to block the cell-signalling molecule could lead to new treatments which would eradicate the conditions.

Study leader Abdolmohamad Rostami said: "This is the first step towards finding a new treatment.

"If we can try to neutralize GM-CSF by different means, for example, by trying to mimic it or trying to block the receptor for GM-CSF, we can hopefully ameliorate the disease."

This follows the development a new treatment for multiple sclerosis which could delay progression of the condition, reports HealthDay News.

Oral drug laquinimod was found to reduce relapse rates in a two year study and to be safe and well tolerated by patients.

Read about Barchester expertise in offering multiple sclerosis support.